Last updated: 25 February 2020 at 4:28pm EST

Thomas R Ii Staab Net Worth




The estimated Net Worth of Thomas R Ii Staab is at least $1.86 Million dollars as of 16 May 2019. Thomas Staab owns over 9,750 units of Biocryst Pharmaceuticals stock worth over $967,610 and over the last 13 years Thomas sold BCRX stock worth over $896,331.

Thomas Staab BCRX stock SEC Form 4 insiders trading

Thomas has made over 45 trades of the Biocryst Pharmaceuticals stock since 2014, according to the Form 4 filled with the SEC. Most recently Thomas sold 9,750 units of BCRX stock worth $74,588 on 16 May 2019.

The largest trade Thomas's ever made was exercising 36,455 units of Biocryst Pharmaceuticals stock on 16 March 2017 worth over $108,271. On average, Thomas trades about 5,224 units every 24 days since 2011. As of 16 May 2019 Thomas still owns at least 125,176 units of Biocryst Pharmaceuticals stock.

You can see the complete history of Thomas Staab stock trades at the bottom of the page.



What's Thomas Staab's mailing address?

Thomas's mailing address filed with the SEC is 4505 EMPEROR BLVD., SUITE 200, DURHAM, NC, 27703.

Insiders trading at Biocryst Pharmaceuticals

Over the last 24 years, insiders at Biocryst Pharmaceuticals have traded over $76,362,383 worth of Biocryst Pharmaceuticals stock and bought 4,042,003 units worth $20,848,654 . The most active insiders traders include Partners L P/Ilbiotechnolog..., Brothers Life Sciences Capi..., and Carl L Gordon. On average, Biocryst Pharmaceuticals executives and independent directors trade stock every 31 days with the average trade being worth of $542,329. The most recent stock trade was executed by Amy E Mc Kee on 24 June 2024, trading 8,600 units of BCRX stock currently worth $54,352.



What does Biocryst Pharmaceuticals do?

biocryst pharmaceuticals, a biotechnology company, designs, optimizes and develops novel small-molecule drugs that block key enzymes involved in infectious and rare diseases. founded in 1986, biocryst has more than 50 employees and is experiencing continued growth. the company’s headquarters are located in research triangle park, north carolina and its discovery center of excellence is in birmingham, alabama. with expertise in drug discovery, clinical development, regulatory affairs and product commercialization, we continue to advance our clinical programs and to generate new compounds from our own discovery engine. we are proud of our culture of engagement and accountability that rewards people for innovative thinking and achievement of key objectives. the commitment of biocryst remains unchanged. we continue to be passionate about developing and marketing novel therapeutics for patients with rare and serious diseases.



What does Biocryst Pharmaceuticals's logo look like?

Biocryst Pharmaceuticals Inc. logo

Complete history of Thomas Staab stock trades at Biocryst Pharmaceuticals

Date
#
Company
Insider
Trans.
Transaction
Shares Price per share Total value Shares after Source
16 May 2019 Thomas R Ii Staab
Senior Vice President and CFO
Sale 9,750 $7.65 $74,588
16 May 2019
125,176
14 May 2019 Thomas R Ii Staab
Senior Vice President and CFO
Sale 11,750 $7.81 $91,768
14 May 2019
130,176
9 May 2019 Thomas R Ii Staab
Senior Vice President and CFO
Option 19,500 $5.51 $107,445
9 May 2019
142,426
2 May 2019 Thomas R Ii Staab
Senior Vice President and CFO
Option 16,750 $5.51 $92,293
2 May 2019
141,676
4 Apr 2019 Thomas R Ii Staab
Senior Vice President and CFO
Option 7,500 $5.51 $41,325
4 Apr 2019
140,176
28 Jan 2019 Thomas R Ii Staab
Senior Vice President and CFO
Option 5,000 $5.45 $27,250
28 Jan 2019
133,426
4 Dec 2018 Thomas R Ii Staab
Senior Vice President and CFO
Sale 3,922 $9.45 $37,063
4 Dec 2018
133,461
21 Nov 2018 Thomas R Ii Staab
Senior Vice President and CFO
Option 15,500 $4.32 $66,960
21 Nov 2018
140,883
19 Nov 2018 Thomas R Ii Staab
Senior Vice President and CFO
Option 11,198 $3.45 $38,633
19 Nov 2018
143,883
7 Nov 2018 Thomas R Ii Staab
Senior Vice President and CFO
Option 14,087 $3.31 $46,628
7 Nov 2018
139,685
5 Nov 2018 Thomas R Ii Staab
Senior Vice President and CFO
Option 215 $3.22 $692
5 Nov 2018
137,598
2 Nov 2018 Thomas R Ii Staab
Senior Vice President and CFO
Option 10,856 $3.40 $36,910
2 Nov 2018
140,883
19 Oct 2018 Thomas R Ii Staab
Senior Vice President and CFO
Option 3,150 $3.78 $11,907
19 Oct 2018
140,533
2 Oct 2018 Thomas R Ii Staab
Senior Vice President and CFO
Option 9,850 $3.41 $33,589
2 Oct 2018
137,483
22 May 2017 Thomas R Ii Staab
Senior Vice President and CFO
Option 7,750 $4.73 $36,658
22 May 2017
149,210
20 Mar 2017 Thomas R Ii Staab
Senior Vice President and CFO
Option 3,250 $3.78 $12,285
20 Mar 2017
144,710
16 Mar 2017 Thomas R Ii Staab
Senior Vice President and CFO
Option 36,455 $2.97 $108,271
16 Mar 2017
153,768
10 Mar 2017 Thomas R Ii Staab
Senior Vice President and CFO
Option 3,250 $3.78 $12,285
10 Mar 2017
120,563
8 Mar 2017 Thomas R Ii Staab
Senior Vice President and CFO
Option 6,500 $3.78 $24,570
8 Mar 2017
123,813
6 Mar 2017 Thomas R Ii Staab
Senior Vice President and CFO
Option 3,250 $3.78 $12,285
6 Mar 2017
120,563
19 Dec 2016 Thomas R Ii Staab
Senior Vice President and CFO
Option 3,250 $3.78 $12,285
19 Dec 2016
127,437
19 Dec 2016 Thomas R Ii Staab
Senior Vice President and CFO
Option 3,250 $3.78 $12,285
19 Dec 2016
127,437
11 Aug 2016 Thomas R Ii Staab
Senior Vice President and CFO
Sale 5,864 $5.18 $30,376
11 Aug 2016
124,187
11 Aug 2016 Thomas R Ii Staab
Senior Vice President and CFO
Sale 5,864 $5.18 $30,376
11 Aug 2016
124,187
9 Aug 2016 Thomas R Ii Staab
Senior Vice President and CFO
Sale 14,577 $4.43 $64,576
9 Aug 2016
130,051
9 Aug 2016 Thomas R Ii Staab
Senior Vice President and CFO
Sale 14,577 $4.43 $64,576
9 Aug 2016
130,051
19 Jan 2016 Thomas R Ii Staab
Senior Vice President and CFO
Option 15,000 $1.81 $27,150
19 Jan 2016
149,916
21 Dec 2015 Thomas R Ii Staab
Senior Vice President and CFO
Sale 3,052 $10.86 $33,145
21 Dec 2015
136,592
17 Dec 2015 Thomas R Ii Staab
Senior Vice President and CFO
Sale 3,000 $10.49 $31,470
17 Dec 2015
139,644
20 Jul 2015 Thomas R Ii Staab
Senior Vice President and CFO
Sale 3,500 $16.50 $57,750
20 Jul 2015
142,644
22 Jun 2015 Thomas R Ii Staab
Senior Vice President and CFO
Option 3,750 $4.73 $17,738
22 Jun 2015
149,894
18 Jun 2015 Thomas R Ii Staab
Senior Vice President and CFO
Sale 16,375 $14.36 $235,145
18 Jun 2015
146,144
5 Jun 2015 Thomas R Ii Staab
Senior Vice President and CFO
Sale 6,000 $12.75 $76,500
5 Jun 2015
153,144
1 Jun 2015 Thomas R Ii Staab
Senior Vice President and CFO
Sale 3,000 $12.00 $36,000
1 Jun 2015
159,144
18 May 2015 Thomas R Ii Staab
Senior Vice President and CFO
Sale 3,000 $11.00 $33,000
18 May 2015
162,144
29 Dec 2014 Thomas R Ii Staab
Senior Vice President and CFO
Option 9,500 $3.78 $35,910
29 Dec 2014
172,442
27 Aug 2014 Thomas R Ii Staab
Senior Vice President and CFO
Option 10,000 $5.45 $54,500
27 Aug 2014
172,942
25 Jul 2014 Thomas R Ii Staab
Senior Vice President and CFO
Option 26,455 $3.78 $100,000
25 Jul 2014
170,756
1 Jul 2014 Thomas R Ii Staab
Senior Vice President and CFO
Option 3,125 $4.73 $14,781
1 Jul 2014
147,426
23 Jun 2014 Thomas R Ii Staab
Senior Vice President and CFO
Option 3,125 $4.73 $14,781
23 Jun 2014
147,426
17 Jun 2014 Thomas R Ii Staab
Senior Vice President and CFO
Option 3,125 $4.73 $14,781
17 Jun 2014
147,426
22 May 2014 Thomas R Ii Staab
Senior Vice President and CFO
Option 17,685 $3.78 $66,849
22 May 2014
144,301
14 Mar 2014 Thomas R Ii Staab
Senior Vice President and CFO
Option 3,125 $4.73 $14,781
14 Mar 2014
129,741
1 Mar 2014 Thomas R Ii Staab
Senior Vice President and CFO
Option 3,000 $4.73 $14,190
1 Mar 2014
129,616
13 Jan 2014 Thomas R Ii Staab
Senior Vice President and CFO
Option 35,225 $3.78 $133,151
13 Jan 2014
84,839


Biocryst Pharmaceuticals executives and stock owners

Biocryst Pharmaceuticals executives and other stock owners filed with the SEC include: